We studied the effects of cyclosporine on experimental cryptococcal meningitis. Like cortisone, cyclosporine depressed the highly effective defense mechanisms of normal rabbits against inoculated Cryptococcus neoformans, causing them to develop progressive, fatal cryptococcal meningitis. Unlike cortisone, which causes a striking reduction in leukocytes in cerebrospinal fluid, cyclosporine depressed mononuclear cell function rather than numbers. Interleukin 2, a primary target for the immunodepressive action of cyclosporine, appears to be of central importance in central nervous system defenses against cryptococci. The findings suggest that humans receiving cyclosporine are likely to suffer increased incidence of cryptococcal infection.
Cyclosporine, a cyclic endecapeptide produced by fungi, is a potent immunosuppressive agent widely used for organ transplantation (4, 11, 18, 30) . Associated opportunistic infections have been reported (10) . Such opportunistic infections probably occur less frequently with cyclosporine than with other standard immunosuppressive drugs such as azathioprine, cyclophosphamide, and corticosteroids (34) , but further studies are needed to confirm this impression.
Cyclosporine can be used as an experimental probe to dissect the roles of immune mechanisms operating against infection. Although further mechanisms of action may yet be discovered, it is clear that cyclosporine has a primary, selective effect on T lymphocytes (1, 20, 21, 24, 37) . It blocks the proliferation of T lymphocytes induced by antigens or mitogens, both by inhibition of synthesis of interleukin 2 (IL-2) and by making T cells unresponsive to IL-2 (5). These actions can prevent transplant rejection in humans and experimental animals, including rabbits (17) .
Cell-mediated immunity is a crucial factor in host defenses against many fungi, including Cryptococcus neoformans (9, 10, 14, 34, 36) . For example, athymic mice have been used to demonstrate the need for functioning T lymphocytes to control cryptococcal infection (5, 16) . We have used cyclosporine to produce a selective block in T-lymphocyte function in rabbits inoculated with cryptococci. Unlike in athymic mice and animals treated with lympholytic doses of corticosteroids, T cells are still present (although functionally suppressed) in cyclosporine-treated rabbits. Their ability to eradicate C. neoformans from the central nervous system was profoundly suppressed by cyclosporine.
MATERIALS AND METHODS Production of meningitis. New Zealand White rabbits, each weighing 2 to 3 kg, were housed in separate cages and given Purina rabbit chow and water ad libitum. A 4-to 5-day growth of C. neoformans (DP strain, serotype A) (32) 25-gauge needle on a 3-ml syringe. Rabbits were sedated on days 4 and 7 after inoculation, and cerebrospinal fluid (CSF) was withdrawn. Quantitative yeast cultures were performed by plating serial dilutions of CSF in phosphate-buffered saline onto Columbia blood agar.
CSF cell populations. CSF leukocytes were counted in Turk solution by using a hemocytometer. Differential leukocyte counts were performed on cytocentrifuged CSF with Giemsa stain. To analyze for lymphocyte subpopulations and phagocytic cells, samples of CSF and blood mononuclear cells were centrifuged at 400 x g for 10 min at 4°C. The supernatant was discarded, and the pellet was resuspended in 200 ,ul of RPMI 1640 (GIBCO Laboratories, Grand Island, N.Y.). The suspension was incubated with latex beads for 1 h at 37°C and centrifuged again. The pellet was resuspended in 100 ,ul of RPMI 1640 supplemented with fetal calf serum (10%) and sodium azide (0.04 g/dl). A 100-,ul portion of 9AE10, a monoclonal mouse immunoglobulin M antibody directed against a rabbit T-lymphocyte antigen (26) , and 10 ,ul of rhodamine-conjugated goat anti-rabbit immunoglobulin (Cappel Laboratories, Cochranville, Pa.) were added, and the mixture was kept on ice for 30 Cyclosporine levels. Three rabbits with cryptococcal meningitis at day 11 received an intravenous bolus of cyclosporine, 30 mg, in cremophor EL. Serum and CSF were drawn 1, 6 , and 24 h and 1 and 24 h later, respectively. Cyclosporine was assayed in these fluids with a commercial radioimmunoassay kit (Sandoz, Inc., East Hanover, N.J.). The sensitivity of the assay was 5 ng/ml or greater.
Statistics. Student from 233 to 784 ng/ml. Cyclosporine was eliminated during 1 day; less than 5 ng/ml was present at 24 h. No cyclosporine was detectable in CSF at either 1 or 24 h after a single dose.
To detect any possible direct antifungal effect of cyclosporine on C. neoformans DP strain, we used a standard method for in vitro broth antifungal susceptibility testing. The inoculum was approximately 5 x 103 CFU/ml in buffered yeast nitrogen base medium incubated at 30°C for 18 to 24 h. There was no effect on yeast growth at up to 100 p.g of cyclosporine per ml. Table 2 shows the effects of cyclosporine and cortisone on the eradication of cryptococci from the CSF of rabbits. Both drugs profoundly inhibited the normal capacity of these rabbits to clear yeasts from CSF. Yeast counts in CSF were significantly higher on days 4 and 7 after inoculation in cyclosporine-and cortisone-treated animals than in untreated animals (P < 0.01). Mortality was much higher in rabbits treated with cyclosporine: 16 of 20 cyclosporinetreated animals died over 4 weeks while none of 18 normal rabbits died (P < 0.001) (one rabbit was killed by CSF withdrawal and was therefore not included in the survival data). The median time between inoculation and death was 11 days, with a range of 5 to 27 days. These deaths could not be attributed to cyclosporine toxicity alone, because only one of five rabbits died within 4 weeks after receiving seven daily treatments of 30 mg of cyclosporine intravenously (P < 0.01). The four cyclosporine-treated rabbits that did survive the infection eventually eradicated C. neoformans from their CSF.
The differential leukocyte counts in peripheral blood on day 3 were similar for the rabbits receiving cyclosporine and those receiving no treatment. Rabbits receiving cortisone had approximately one-half the total number of blood lymphocytes compared with the other two groups. The effects of cyclosporine and cortisone on leukocyte counts in CSF are presented in Table 3 . The characteristic CSF leukopenia found in cortisone-treated rabbits did not occur in cyclosporine-treated animals. Although the median cell count was somewhat lower after cyclosporine treatment (0.05 < P < 0.10 by the Wilcoxon rank sum test compared with normal rabbits), there was considerable overlap between CSF cell counts in the cyclosporine-treated and untreated groups. This finding contrasts with the effect of cortisone treatment, which reduces all lymphocyte subpopulations, including the predominant T lymphocyte, to very low numbers in the CSF. Examination of lymphocyte subpopulations on day 4 showed that cyclosporine did not alter their relative proportions in CSF (Table 4) .
Because there was little or no effect on the quantitative host cellular response in the CSF during cyclosporine treatment, we examined lymphocyte function. Functional assays of rabbit CSF lymphocytes are technically difficult because of the small number of cells available, so we examined some functional capabilities of blood lymphocytes. Figure 1 shows the mitogenic lymphocyte stimulation in vitro of peripheral blood cells in individual rabbits infected with C. neoformans and receiving either cyclosporine for 4 to 5 days or no treatment. Con A acted as a strong mitogen for all rabbits studied. Treatment with cyclosporine in vivo significantly reduced the response to Con A. There was no effect on spontaneous lymphocyte transformation: median counts were 208 cpm (range, 97 to 1,134) for cyclosporine-treated animals compared with 210 cpm (77 to 832) for untreated animals. However, there was a significant reduction in the response to Con A: median counts were 395 cpm for cyclosporine-treated animals and 1,996 cpm for those receiving no treatment (P < 0.01). For the median stimulation index, which was 2.1 (1.1 to 3.9) versus 11.8 (5.8 to 32.9), respectively, there was no overlap between individual rabbits in each group. However, lymphocytes from rabbits receiving cyclosporine or no treatment responded equally well to exogenous human IL-2 in vitro. There was an increase in spontaneous lymphocyte transformation in all rabbits when IL-2 was incubated with the blood mononuclear cells in vitro. There was no significant difference between cyclosporine-treated animals (mean, 2,636 + 861 cpm) versus normal animals (mean, 1,828 ± 456 cpm). Thus, the lymphocytes of cyclosporine-treated animals remained responsive to exogenous DISCUSSION
The extent to which cyclosporine causes opportunistic infection during clinical use in humans remains to be defined. Experience after organ transplantation suggests that serious infections caused by a variety of opportunistic pathogens can occur in patients receiving cyclosporine (4, 10, 18, 30) . A few patients have developed serious disseminated mycoses, including cryptococcosis, while receiving cyclosporine (10) . However, some reports suggest that the incidence of such infections is much lower than with older immunosuppressive regimens (34) . The true relationship between cyclosporine treatment and opportunistic infection is further confused by the frequent practice of using cyclosporine and corticosteroids together (4, 30) . The immune response to C. neoformans is incompletely understood. For example, the importance or otherwise of the humoral response to this infection remains unproven (7, 15, 25, 27, 33) . On the other hand, the cellular immunity limb has been emphasized as an extremely important factor in cryptococcosis (10, 17, 37) . Most patients have underlying diseases that could depress cellular immunity or have received corticosteroids or other immunosuppressive drugs (8) . Even apparently normal patients who develop cryptococcal meningitis may have abnormal lymphocyte function (9, 14, 36) . Cyclosporine-treated rabbits provide a model in which the mitogenic responses of blood lymphocytes are likewise reduced. Previous in vitro and in vivo studies have shown the importance of NK cells (28) , antigen-induced suppressor T cells (29) , and activated macrophages in the eradication of C. neoformans from the animal host (12) . The athymic mouse model has demonstrated the primary importance of T-cell function in the immune response of the host to C. neoformans (5, 16 (8) . In contrast, cyclosporine treatment has little or no effect on the number of cells at the site of infection. Thus, while cyclosporine induces a definable functional abnormality, cortisone causes multiple quantitative and qualitative changes which make any functional defects much more difficult to define (7, 33) . Cryptococcal meningitis progressed more rapidly to death in rabbits treated with cyclosporine than in those treated with cortisone. Median time to death was approximately 2 weeks with cyclosporine at the doses used in this study, compared with approximately 4 weeks with cortisone (33).
Although we have shown a striking suppression of the immune response to C! neoformans in the central nervous system of rabbits, cyclosporine may be less detrimental for the host response to other species of fungi and protozoa. Cyclosporine has direct inhibitory actions on schistosomes (2) and malaria parasites (38) . The growth of certain fungal species, including Coccidioides imitis, can also be inhibited by this drug both in vitro and in vivo (23) . Thus for some mycotic infections there may be a complicated balance between the effects of the immune suppression and the direct antifungal activity of this agent. We found no direct effect of cyclosporine on growth of the C. neoformans strain used in our experiments. Therefore, the primary action of cyclosporine in our model must be immune suppression. We were not able to measure cyclosporine in CSF after a single dose, but serum concentrations were comparable to those found in humans, where the therapeutic range is 100 to 1,000 ng/ml and trough levels are 100 to 400 ng/ml. Levels of 1,000 nglml have been shown to suppress cellular proliferative and cytotoxic T-cell generation completely in mixed lymphocyte culture (22) . Peak concentrations of cyclosporine in rabbits during treatment approached this level, and it was able to block the effective killing mechanisms for C. neoformans in rabbits. The absence of detectable cyclosporine in the CSF suggests that it acts on imm,unocytes before they reach the actual site of infection in the central nervous system. The observed differences in effects on the host response by these two immunosuppressive agents against C. neoformans suggest that a combination of the agents would greatly potentiate the degree of immune dysfunction. It is likely that the use of cyclosporine and corticosteroids together will increase the frequency and severity of infection with C. neoformans or other pathogens, such as Pneumocystis carinii, normally controlled by cellular immnunity. Cyclosporine, like corticosteroids, increases the frequency of Pneumocystis infections in rats (19) .
Cyclosporine represents a great advance in prevention of graft rejection, despite side effects such as nephrotoxicity, defective tumor surveillance, and infections (22) . Our studies on cryptococcosis in cyclosporine-treated rabbits help to identify the mechanisms which kill these yeasts efficiently in normal rabbits. Further studies will define these mechanisms more fully, perhaps leading to interventions which could reduce the risk of opportunistic infections or help in management of those which do occur. Meanwhile, we predict that more cases of cryptococcosis will occur in patients receiving cyclosporine, especially if it is combined with corticosteroid therapy.
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